生物活性 | |||
---|---|---|---|
描述 | Evatanepag (CP-533536) is a non-prostanoid, potent, and selective EP2 receptor agonist. It induces local bone formation in vivo and can be utilized in research related to fractures, bone defects, and asthma [1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.13mL 0.43mL 0.21mL |
10.67mL 2.13mL 1.07mL |
21.34mL 4.27mL 2.13mL |
参考文献 |
---|